An impressive oral presentation at HIV Glasgow 2024 reported on how increasing access to effective hepatitis C treatment has dramatically reduced HCV prevalence among people living with HIV in Spain.
The study, presented by Juan Berenguer from Gregorio Marañón Hospital in Madrid, combined results from nine cross-sectional studies from the last 20 years. It included results from 43 centres in 32 cities in 14 of the 17 regions in Spain and represented approximately a third of the people living with HIV nationally. It included approximately 47,000 people each year, of whom >99% were on ART and had HCV test results.
Read the full report by Simon Collins, HIV i-Base here.
All HIV i-Base reports from HIV Glasgow 2024 can be accessed here.
Source : HIV i-Base
Related HIV and Co-Infections News
-
2024 NGO Report: Breaking the chains: supporting community leadership and human rights for a sustainable HIV response
-
Unitaid invests US$22m to accelerate access to lenacapavir, a groundbreaking new HIV prevention drug
-
Biden-Harris administration policy expands access to life-saving organs for people with HIV
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.